Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study†
Corresponding Author
Thomas M. Habermann
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Mayo Clinic, Division of Hematology, 200 First Street SW, Rochester, MN 55905Search for more papers by this authorCarrie A. Thompson
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorBetsy R. LaPlant
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorBrent A. Bauer
Division of General Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorCarol A. Janney
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorMatthew M. Clark
Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorTeresa A. Rummans
Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorMatthew J. Maurer
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorJeff A. Sloan
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorSusan M. Geyer
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorJames R. Cerhan
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorCorresponding Author
Thomas M. Habermann
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Mayo Clinic, Division of Hematology, 200 First Street SW, Rochester, MN 55905Search for more papers by this authorCarrie A. Thompson
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorBetsy R. LaPlant
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorBrent A. Bauer
Division of General Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorCarol A. Janney
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorMatthew M. Clark
Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorTeresa A. Rummans
Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorMatthew J. Maurer
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorJeff A. Sloan
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorSusan M. Geyer
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorJames R. Cerhan
Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Search for more papers by this authorConflict of interest: Nothing to report.
Abstract
No published survey has specifically addressed the beliefs, knowledge, and usage of complementary and alternative medicine (CAM) in long-term (5–20 years) lymphoma survivors alone. In this pilot project, 95 subjects were randomly selected from a population of 2,475 long-term lymphoma survivors and mailed a questionnaire. The median time from lymphoma diagnosis to completion of the questionnaire was 11 years (range 6–20). Overall, 68% (95% CI: 54–80%) of the long-term lymphoma survivors reported that they have used CAM, a rate higher than the estimated usage rate reported for the general population The most commonly used modalities were chiropractic (39%, 95% CI: 27–53%) and massage therapy (21%, 95% CI: 12–34%). Less than 10% used meditation (5%, 95% CI: 1–15%) and relaxation (7%, 95% CI: 2–17%). In terms of common herbal usage, 5% (95% CI: 1–15%) had used St. John's Wort and 7% (95% CI: 2–17%) had used shark cartilage. Although none of the patients reported that CAM usage was directed specifically towards treating their lymphoma, 4% (95% CI: 0–12%) of patients reported that CAM could cure cancer, and 14% (95% CI: 6–26%) reported that CAM could increase their feeling of control over their health. This pilot study suggests that long-term lymphoma survivors appear to use CAM at a rate higher than the general population. The use of potential agents of risk by the survivors and the lack of access to potentially beneficial modalities highlights the need for further study of CAM in this population. Am. J. Hematol., 2009. © 2009 Wiley-Liss, Inc.
References
- 1 Barnes PM,Powell-Griner E,McFann K,Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343: 1–19.
- 2 Rhee SM,Garg VK,Hershey CO. Use of complementary and alternative medicines by ambulatory patients. Arch Intern Med 2004; 164: 1004–1009.
- 3
Gordon NP,Lin TY.
Use of complementary and alternative medicine by the adult membership of a large northern California health maintenance organization, 1999.
J Ambul Care Manage
2004;
27:
12–24.
10.1097/00004479-200401000-00004 Google Scholar
- 4 Ni H,Simile C,Hardy AM. Utilization of complementary and alternative medicine by United States adults: Results from the 1999 national health interview survey. Med Care 2002; 40: 353–358.
- 5 Gray CM,Tan AW,Pronk NP,O'Connor PJ. Complementary and alternative medicine use among health plan members. A cross-sectional survey. Eff Clin Pract 2002; 5: 17–22.
- 6 Eisenberg DM,Davis RB,Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA 1998; 280: 1569–1575.
- 7 DeBar LL,Vuckovic N,Schneider J,Ritenbaugh C. Use of complementary and alternative medicine for temporomandibular disorders. J Orofac Pain 2003; 17: 224–236.
- 8 Hsiao AF,Wong MD,Kanouse DE, et al. Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr 2003; 33: 157–165.
- 9 Wood MJ,Stewart RL,Merry H, et al. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003; 145: 806–812.
- 10 Yeh GY,Eisenberg DM,Davis RB,Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: Results of a national survey. Am J Public Health 2002; 92: 1648–1652.
- 11 Matthees BJ,Anantachoti P,Kreitzer MJ, et al. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung 2001; 30: 258–268.
- 12 Liu EH,Turner LM,Lin SX, et al. Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2000; 120: 335–341.
- 13 Richardson MA,Sanders T,Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505–2514.
- 14 Bernstein BJ,Grasso T. Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park) 2001; 15: 1267–1272; discussion1272–1278,1283.
- 15 Maskarinec G,Shumay DM,Kakai H,Gotay CC. Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med 2000; 6: 531–538.
- 16 Sparber A,Bauer L,Curt G, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum 2000; 27: 623–630.
- 17 Gotay CC. Use of complementary and alternative medicine in Hawaii cancer patients. Hawaii Med J 1999; 58: 49–51,54–55.
- 18 Wyatt GK,Friedman LL,Given CW, et al. Complementary therapy use among older cancer patients. Cancer Pract 1999; 7: 136–144.
- 19
Ernst E,Cassileth BR.
The prevalence of complementary/alternative medicine in cancer: A systematic review.
Cancer
1998;
83:
777–782.
10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- 20 Maskarinec G,Gotay CC,Tatsumura Y, et al. Perceived cancer causes: Use of complementary and alternative therapy. Cancer Pract 2001; 9: 183–190.
- 21 Boon H,Stewart M,Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. J Clin Oncol 2000; 18: 2515–2521.
- 22 Henderson JW,Donatelle RJ. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med 2004; 10: 52–57.
- 23 Shen J,Andersen R,Albert PS, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2002; 2: 8–14.
- 24 DiGianni LM,Garber JE,Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002; 20: 34S–38S.
- 25 Lee MM,Lin SS,Wrensch MR, et al. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 2000; 92: 42–47.
- 26 VandeCreek L,Rogers E,Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 1999; 5: 71–76.
- 27 Eng J,Ramsum D,Verhoef M, et al. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2003; 2: 212–216.
- 28 Boon H,Westlake K,Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: Prevalence and characteristics. Urology 2003; 62: 849–853.
- 29 Diefenbach MA,Hamrick N,Uzzo R, et al. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol 2003; 170: 166–169.
- 30 Wilkinson S,Gomella LG,Smith JA, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol 2002; 168: 2505–2509.
- 31
Kao GD,Devine P.
Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy.
Cancer
2000;
88:
615–619.
10.1002/(SICI)1097-0142(20000201)88:3<615::AID-CNCR18>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 32 Nam RK,Fleshner N,Rakovitch E, et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 1999; 161: 1521–1524.
- 33 Swisher EM,Cohn DE,Goff BA, et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol 2002; 84: 363–367.
- 34 Kullmer U,Stenger K,Milch W, et al. Self-concept, body image, and use of unconventional therapies in patients with gynaecological malignancies in the state of complete remission and recurrence. Eur J Obstet Gynecol Reprod Biol 1999; 82: 101–106.
- 35 Munstedt K,Kirsch K,Milch W, et al. Unconventional cancer therapy–survey of patients with gynaecological malignancy. Arch Gynecol Obstet 1996; 258: 81–88.
- 36 Von Gruenigen VE,White LJ,Kirven MS, et al. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 2001; 11: 205–209.
- 37
Mottonen M,Uhari M.
Use of micronutrients and alternative drugs by children with acute lymphoblastic leukemia.
Med Pediatr Oncol
1997;
28:
205–208.
10.1002/(SICI)1096-911X(199703)28:3<205::AID-MPO10>3.0.CO;2-D CAS PubMed Web of Science® Google Scholar
- 38 Gupta M,Shafiq N,Kumari S,Pandhi P. Patterns and perceptions of complementary and alternative medicine (CAM) among leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital. Pharmacoepidemiol Drug Saf 2002; 11: 671–676.
- 39 Patterson RE,Neuhouser ML,Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: Predictors, motives, and costs. J Altern Complement Med 2002; 8: 477–485.
- 40 Dinehart SM,Alstadt K. Use of alternative therapies by patients undergoing surgery for nonmelanoma skin cancer. Dermatol Surg 2002; 28: 443–446.
- 41 Warrick PD,Irish JC,Morningstar M, et al. Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1999; 125: 573–579.
- 42 Yates P,Beadle G,Clavarin A, et al. Patients with terminal cancer who use alternative therapies: Their beliefs and practices. Sociol Health Illn 1993; 15: 199–217.
- 43 Yates JS,Mustian KM,Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005; 13: 806–811.
- 44 Gotay CC,Dumitriu D. Health food store recommendations for breast cancer patients. Arch Fam Med 2000; 9: 692–699.
- 45 Loprinzi CL,Levitt R,Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer: A North Central Cancer Treatment Group trial. Cancer 2005; 104: 176–182.
- 46 Yates KM,O'Connor A,Horsley CA. “Herbal Ecstasy”: A case series of adverse reactions. NZ Med J 2000; 113: 315–317.
- 47 Soon SL,Crawford RI. Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol 2001; 44: 298–299.
- 48 Grouhi M,Sussman G. Pseudoallergic toxic reaction. Ann Allergy Asthma Immunol 2000; 85: 269–271.
- 49
Shannon M.
Alternative medicines toxicology: A review of selected agents.
J Toxicol Clin Toxicol
1999;
37:
709–713.
10.1081/CLT-100102448 Google Scholar
- 50 Cassileth BR. Complementary therapies: Overview and state of the art. Cancer Nurs 1999; 22: 85–90.
- 51 Stasi R,Abriani L,Beccaglia P, et al. Cancer-related fatigue: Evolving concepts in evaluation and treatment. Cancer 2003; 98: 1786–1801.
- 52 Curt G,Johnston PG. Cancer fatigue: The way forward. Oncologist 2003; 8( Suppl 1): 27–30.
- 53 Thomas SF,Glynne-Jones R,Chait I,Marks DF. Anxiety in long-term cancer survivors influences the acceptability of planned discharge from follow-up. Psychooncology 1997; 6: 190–196.
- 54 Rummans TA,Clark MM,Sloan JA, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: A randomized controlled trial. J Clin Oncol 2006; 24: 635–642.